NCT Number: NCT05445609
Phase: PHASE2
Trial Summary: This phase II trial tests whether vidutolimod with nivolumab works to destroy tumor cells in patients with castration resistant prostate cancer that has spread to other places in the body (metastatic) – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Emory University
Acronym:
Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives